Get notified when ACN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Government Investigation (unchanged) — The disclosure of the DOJ investigation into AFS remains in the current filing, indicating the matter is ongoing and could have adverse consequences.
Accenture's fiscal 2026 revenue rose 6.5% to $74.18B, and diluted EPS increased 11.6% to $13.56.
Filed October 16, 2026 · Period ending August 31, 2026 · Compared to 10-K Oct 10, 2025 · ~1 min read
Key Changes
-
high
Operating margin expanded to 15.4% from 14.7%, as business optimization costs fell to $307.5M from $615.3M.
-
high
The company returned $11.5 billion to shareholders, including share purchases of $7.52B and dividends of $3.99B.
-
medium
Long-term debt nearly doubled to $10.00B from $5.03B.
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MRSH 10-Q) is open in full — no account needed.
Partner
Trade ACN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 16, 2026 · How we verify